The 52 Week Low is $181.77 set on Thu, Mar 12, 2020.
The 52 Week High is $262.82 set on Mon, Jul 20, 2020.
The All-Time High is $262.82 set on Mon, Jul 20, 2020.
Earnings Per Share
Price To Earnings Ratio
Dividend Payment Date
Amgen trades on the NASDAQ. AMGN's market cap is 140.8 Billion.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).